Cyclosporiasis Update
While one source has been identified in the cyclosporiasis outbreak in Michigan and surrounding states, the investigation is continuing as there are likely several concurrent
Author: TAG
Grower Considerations for Cyclospora Prevention and Control
After declaring that the positive for cyclospora on iceberg lettuce was a false positive, the FDA is continuing to investigate the source of the multi-state
What Is Cyclospora and Why Is It Such a Problem?
A microscopic parasite called Cyclospora cayetanensis has sickened more than 2,600 people in Michigan this summer, spreading across 55 counties in a state that normally
Linking Inspection Data with Outbreak Data Furthers Prevention
Although restaurants are implicated in 64% of foodborne illness outbreaks in the U.S. and are generally inspected at least annually (depending on state requirements and
Coadministration of Flu and Covid Shots Not a Risk
Getting a flu shot and COVID-19 shot at the same time is safe and has no increased risk of adverse effects. New research, published in
Does Your Food Packaging Address Today’s Concerns and Evolving Regulations?
New California and European Union regulations are making packaging more difficult for the food industry while forcing health and sustainability considerations. California’s SB54 (in effect
Out-of-Season Flu Outbreak Shows How Conditions Can Increase Potential
Influenza outbreaks are not typical for this time of year, yet they can and do occur as illustrated by the nearly 300 cases reported among
New Pesticide Monitoring Plan Could Notably Impact Industry … or Not
Although FDA’s recent updates to its Pesticide Monitoring Compliance Program have not received much media attention, the food industry could feel some distinct impacts, particularly
Cantaloupe Safety
With all the publicity on cantaloupe, I can’t help but wonder: Is it safe to eat? The short answer: Yes, if … The explanation: Cantaloupes
New mRNA Flu Vaccine Being Considered for Fall Use
In February, FDA announced that it would not review Moderna’s mRNA influenza vaccine; reversed its position about a week later; and now has agreed to